Spinal cord pathology in alpha-synuclein transgenic mice

Parkinson's Disease

Volumn , Issue , 2010, Pages

  Mendritzki, Sonja ^a   Schmidt, Saskia ^a   Sczepan, Teresa ^a   Zhu, Xin Ran ^a   Segelcke, Daniel ^a   Lübbert, Hermann ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DEATH; GLIOSIS; IMMUNOHISTOCHEMISTRY; MICROGLIA; MOTOR DYSFUNCTION; MOUSE; NONHUMAN; OLIGODENDROGLIA; PARKINSON DISEASE; PRIORITY JOURNAL; SPINAL CORD; TRANSGENIC MOUSE;

EID: 77955970034     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.4061/2010/375462     Document Type: Article

References (33)

1. Biskup S., Gerlach M., Kupsch A., Reichmann H., Riederer P., Vieregge P., Wllner U., Gasser T., Genes associated with Parkinson syndrome Journal of Neurology 2008 255 5, supplement 8 17
2. Farrer M. J., Genetics of Parkinson disease: paradigm shifts and future prospects Nature Reviews Genetics 2006 7 4 306 318
3. Duda J. E., Giasson B. I., Gur T. L., Montine T. J., Robertson D., Biaggioni I., Hurtig H. I., Stern M. B., Gollomp S. M., Grossman M., Lee V. M.-Y., Trojanowski J. Q., Immunohistochemical and biochemical studies demonstrate a distinct profile of -synuclein permutations in multiple system atrophy Journal of Neuropathology and Experimental Neurology 2000 59 9 830 841
4. Baba M., Nakajo S., Tu P.-H., Tomita T., Nakaya K., Lee V. M.-Y., Trojanowski J. Q., Iwatsubo T., Aggregation of -synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies American Journal of Pathology 1998 152 4 879 884
5. Schapira A. H., Mitochondria in the aetiology and pathogenesis of Parkinson's disease The Lancet Neurology 2008 7 1 97 109
6. Ross C. A., Smith W. W., Gene-environment interactions in Parkinson's disease Parkinsonism and Related Disorders 2007 13 supplement 3 S309 S315
7. Maskri L., Zhu X., Fritzen S., Khn K., Ullmer C., Engels P., Andriske M., Stichel C. C., Lbbert H., Influence of different promoters on the expression pattern of mutated human -synuclein in transgenic mice Neurodegenerative Diseases 2004 1 6 255 265
8. Zhu X.-R., Maskri L., Herold C., Bader V., Stichel C. C., Gntrkn O., Lbbert H., Non-motor behavioural impairments in parkin-deficient mice European Journal of Neuroscience 2007 26 7 1902 1911
9. Stichel C. C., Zhu X.-R., Bader V., Linnartz B., Schmidt S., Lbbert H., Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage Human Molecular Genetics 2007 16 20 2377 2393
10. Schmidt S., Linnartz B., Mendritzki S., Sczepan T., Stichel C. C., Lbbert H., Transgenic mouse models for Parkinson's disease display structural and functional pathology in glial mitochondria. Submitted to Human Molecular Genetics
11. Austin S. A., Floden A. M., Murphy E. J., Combs C. K., -synuclein expression modulates microglial activation phenotype Journal of Neuroscience 2006 26 41 10558 10563
12. Solano R. M., Casarejos M. J., Menndez-Cuervo J., Rodriguez-Navarro J. A., De Ybenes J. G., Mena M. A., Glial dysfunction in parkin null mice: effects of aging Journal of Neuroscience 2008 28 3 598 611
13. Nagai M., Re D. B., Nagata T., Chalazonitis A., Jessell T. M., Wichterle H., Przedborski S., Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons Nature Neuroscience 2007 10 5 615 622
14. Shults C. W., Rockenstein E., Crews L., Adame A., Mante M., Larrea G., Hashimoto M., Song D., Iwatsubo T., Tsuboi K., Masliah E., Neurological and neurodegenerative alterations in a transgenic mouse model expressing human -synuclein under oligodendrocyte promoter: implications for multiple system atrophy Journal of Neuroscience 2005 25 46 10689 10699
15. Yazawa I., Giasson B. I., Sasaki R., Zhang B., Joyce S., Uryu K., Trojanowski J. Q., Lee V. M.-Y., Mouse model of multiple system atrophy -synuclein expression in oligodendrocytes causes glial and neuronal degeneration Neuron 2005 45 6 847 859
16. Bodis-Wollner I., Neuropsychological and perceptual defects in Parkinson's disease Parkinsonism and Related Disorders 2003 9 supplement 2 S83 S89
17. Braak H., del Tredici K., Rb U., De Vos R. A. I., Jansen Steur E. N. H., Braak E., Staging of brain pathology related to sporadic Parkinson's disease Neurobiology of Aging 2003 24 2 197 211
18. Langston J. W., The Parkinson's complex: Parkinsonism is just the tip of the Iceberg Annals of Neurology 2006 59 4 591 596
19. Klos K. J., Ahlskog J. E., Josephs K. A., Apaydin H., Parisi J. E., Boeve B. F., DeLucia M. W., Dickson D. W., -synuclein pathology in the spinal cords of neurologically asymptomatic aged individuals Neurology 2006 66 7 1100 1102
20. Gallyas F., Wolff J. R., Boettcher H., Zaborszky L., A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system Stain Technology 1980 55 5 299 306
21. Liu H. M., Bahu R. M., Ultrastructure of the nervous system Annals of Clinical and Laboratory Science 1975 5 348 354
22. Peters A., Palay S. L., Webster H., The Fine Structure of the Nervous System 1976 Philadelphia, Pa, USA W.B. Saunders
23. Braak H., Mller C. M., Rb U., Ackermann H., Bratzke H., De Vos R. A. I., Del Tredici K., Pathology associated with sporadic Parkinson's diseasewhere does it end? Journal of Neural Transmission, Supplement 2006 70 89 97
24. Martin L. J., Pan Y., Price A. C., Sterling W., Copeland N. G., Jenkins N. A., Price D. L., Lee M. K., Parkinson's disease -synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death Journal of Neuroscience 2006 26 1 41 50
25. Neumann M., Kahle P. J., Giasson B. I., Ozmen L., Borroni E., Spooren W., Mller V., Odoy S., Fujiwara H., Hasegawa M., Iwatsubo T., Trojanowski J. Q., Kretzschmar H. A., Haass C., Misfolded proteinase K-resistant hyperphosphorylated -synuclein in aged transgenic mice with locomotor deterioration and in human -synucleinopathies Journal of Clinical Investigation 2002 110 10 1429 1439
26. Sasaki S., Shirata A., Yamane K., Iwata M., Involvement of spinal motor neurons in parkin-positive autosomal recessive juvenile parkinsonism Neuropathology 2008 28 1 74 80
27. Surmeier D. J., Calcium, ageing, and neuronal vulnerability in Parkinson's disease The Lancet Neurology 2007 6 10 933 938
28. Von Coelln R., Thomas B., Andrabi S. A., Kah L. L., Savitt J. M., Saffary R., Stirling W., Bruno K., Hess E. J., Lee M. K., Dawson V. L., Dawson T. M., Inclusion body formation and neurodegeneration are parkin independent in a mouse model of -synucleinopathy Journal of Neuroscience 2006 26 14 3685 3696
29. Vila M., Jackson-Lewis V., Gugan C., Chu Wu D., Teismann P., Choi D.-K., Tieu K., Przedborski S., The role of glial cells in Parkinson's disease Current Opinion in Neurology 2001 14 4 483 489
30. Giasson B. I., Duda J. E., Quinn S. M., Zhang B., Trojanowski J. Q., Lee V. M.-Y., Neuronal -synucleinopathy with severe movement disorder in mice expressing A53T human -synuclein Neuron 2002 34 4 521 533
31. Lee M. K., Stirling W., Xu Y., Xu E., Qui D., Mandir A. S., Dawson T. M., Copeland N. G., Jenkins N. A., Price D. L., Human -synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with -synuclein aggregation in transgenic mice Proceedings of the National Academy of Sciences of the United States of America 2002 99 13 8968 8973
32. Fahn S., Description of Parkinson's disease as a clinical syndrome Annals of the New York Academy of Sciences 2003 991 1 14
33. Komada M., Takao K., Miyakawa T., Elevated plus maze for mice Journal of Visualized Experiments 2008 1088 22